Products - B2B

Disclaimer: Availability of products is subject to patent restrictions in countries where applicable patents are in effect.

Download PDF
Product Name Strength and Dosage form Brand/Innovator Indication Dossier Availability
LAPATINIB 250mg Film-coated tablets Tyverb® (Novartis) Breast cancer YES
LETROZOLE 2.5mg Film-coated tablets Femara® (Novartis) Breast cancer YES
VENETOCLAX 10mg, 50mg, 100mg Film-coated tablets Venclyxto® (Abbvie) Leukemia Q1-2027
METHOTREXATE 2.5mg Film-coated tablets Novatrex® (Pfizer) Antimetabolite/Immunosuppressant YES
ABIRATERONE 250mg, 500mg & 1000mg Film-coated tablets Zytiga® (Janssen) Prostate cancer YES
APALUTAMIDE 60mg & 240mg Film-coated tablets Erleada® (Janssen) Prostate cancer Q3-2027
ENZALUTAMIDE 40mg & 80mg Film-coated tablets Xtandi® (Astellas) Prostate cancer Q3-2026
PAZOPANIB 200mg & 400mg Film-coated tablets Votrient® (Novartis) Renal cell cancer YES
EMPAGLIFLOZIN 10mg, 25mg Film-coated tablets Jardiance® (Boehringer) Type 2 - Diabetes Mellitus Q1-2026
EMPAGLIFLOZIN / LINAGLIPTIN 10mg/5mg & 25mg/5mg Film-coated tablets Glyxambi® (Boehringer) Type 2 - Diabetes Mellitus Q4-2026

* Available for distribution only.